Exelixis, Inc. (NASDAQ:EXEL) Shares Sold by JPMorgan Chase & Co.
JPMorgan Chase & Co. lowered its position in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 25.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,314,575 shares of the biotechnology company’s stock after selling 1,116,078 shares during the quarter. JPMorgan Chase […]
JPMorgan Chase & Co. lowered its position in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 25.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,314,575 shares of the biotechnology company’s stock after selling 1,116,078 shares during the quarter. JPMorgan Chase […]
